Ispecimen Inc (ISPC)

$0.39 +0.01 (1.89%)
Market Cap 3.72M
Revenue (ttm) 9.29M
Net Income (ttm) -12.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -134.55%
Debt to Equity Ratio 0.00
Volume 265,900
Avg Vol 376,406
Day's Range N/A - N/A
Shares Out 9.77M
Stochastic %K 23%
Beta 1.80
Analysts Strong Buy
Price Target $4.25

Company Profile

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal m...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 301 6700
Address:
8 Cabot Road, Woburn, United States
StarGazerStox
StarGazerStox Dec. 24 at 10:22 AM
$ISPC The next phase will be defined by how internal discipline offsets macro and competitive headwinds. Long-term optimism depends on disciplined follow-through.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 23 at 6:02 AM
$ISPC RSI: 41.30, MACD: -0.0649 Vol: 0.04, MA20: 0.45, MA50: 0.60 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
peanuta
peanuta Dec. 23 at 1:42 AM
$ISPC swim keeps buying when it gets to 37cent land. why? if this is going to crap out, why?
0 · Reply
peanuta
peanuta Dec. 22 at 8:50 PM
$ISPC i just figured it out. i am the guy buying what you are selling. sux being me.
0 · Reply
peanuta
peanuta Dec. 22 at 8:23 PM
$ISPC always in like a lion, out like a lamb
0 · Reply
FullPorrtDipz
FullPorrtDipz Dec. 22 at 7:33 PM
$ISPC what price the warranta at?
0 · Reply
peanuta
peanuta Dec. 22 at 6:39 PM
$ISPC is today the after hour run? $.50? i hope so. i doubt it. but hope is good.
0 · Reply
peanuta
peanuta Dec. 22 at 5:08 PM
$ISPC for a stock that is screwed, someone keeps buying
0 · Reply
DELETE26
DELETE26 Dec. 22 at 8:21 AM
$ISPC 0.414
0 · Reply
DELETE26
DELETE26 Dec. 19 at 6:19 PM
$ISPC If a stock is falling every day, that stock is screwed.
0 · Reply
Latest News on ISPC
iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

Sep 4, 2025, 4:05 PM EDT - 3 months ago

iSpecimen Approached by Crypto Currency Companies for $200 Million Treasury Discussions

iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform

Aug 21, 2025, 8:00 AM EDT - 4 months ago

iSpecimen Announces Completion of Milestone 1 in Digital Transformation Journey with Salestack Platform

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

Aug 7, 2025, 4:05 PM EDT - 4 months ago

iSpecimen to Establish $200M Corporate Treasury Built Around Solana Cryptocurrency with BlockArrow

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

Aug 4, 2025, 6:45 PM EDT - 5 months ago

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

Jul 31, 2025, 4:06 PM EDT - 5 months ago

iSpecimen Inc. Announces Pricing of Approximately $1.75 Million Private Placement Priced At-the-Market

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 28, 2025, 4:35 PM EDT - 5 months ago

Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jul 28, 2025, 4:30 PM EDT - 5 months ago

Correction: iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

Jul 25, 2025, 1:53 PM EDT - 5 months ago

iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering

iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

Jul 24, 2025, 8:30 AM EDT - 5 months ago

iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

Jan 16, 2025, 4:01 PM EST - 1 year ago

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Dec 20, 2024, 8:30 AM EST - 1 year ago

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

Dec 13, 2024, 7:30 AM EST - 1 year ago

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

iSpecimen Appoints Robert Lim as CEO and Director

Dec 12, 2024, 5:11 PM EST - 1 year ago

iSpecimen Appoints Robert Lim as CEO and Director

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Nov 8, 2024, 7:30 AM EST - 1 year ago

iSpecimen Named Top Competitor in $4.4 Billion USD Market

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

Nov 7, 2024, 7:30 AM EST - 1 year ago

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Oct 31, 2024, 3:07 PM EDT - 1 year ago

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Oct 30, 2024, 8:30 AM EDT - 1 year ago

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

Sep 26, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Secures $1 Million Loan; Appoints Three New Board Members

iSpecimen Announces 1-for-20 Reverse Stock Split

Sep 11, 2024, 4:30 PM EDT - 1 year ago

iSpecimen Announces 1-for-20 Reverse Stock Split

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 7:14 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript

iSpecimen Reports Second Quarter 2024 Results

Aug 6, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports Second Quarter 2024 Results

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

May 12, 2024, 8:24 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript

iSpecimen Reports First Quarter 2024 Results

May 7, 2024, 7:30 AM EDT - 1 year ago

iSpecimen Reports First Quarter 2024 Results

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 10:40 AM EDT - 1 year ago

iSpecimen Inc. (ISPC) Q4 2023 Earnings Call Transcript

iSpecimen Reports Full Year 2023 Results

Mar 14, 2024, 8:00 AM EDT - 1 year ago

iSpecimen Reports Full Year 2023 Results

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

Mar 12, 2024, 7:07 PM EDT - 1 year ago

iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

Mar 5, 2024, 4:30 PM EST - 1 year ago

iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

Jan 23, 2024, 7:30 AM EST - 2 years ago

iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

Jan 18, 2024, 8:11 AM EST - 2 years ago

iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024

iSpecimen Strengthens Global Oncology Biospecimen Offering

Dec 7, 2023, 7:30 AM EST - 2 years ago

iSpecimen Strengthens Global Oncology Biospecimen Offering

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

Nov 3, 2023, 4:39 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

Nov 2, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Reports Third Quarter 2023 Financial and Operating Results

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

Oct 26, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

Oct 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers

Sep 28, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers

iSpecimen Expands Provider Network to Enhance Support for Women's Health Research

Sep 13, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Expands Provider Network to Enhance Support for Women's Health Research

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

Sep 6, 2023, 4:05 PM EDT - 2 years ago

iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

Sep 6, 2023, 7:36 AM EDT - 2 years ago

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

BIVI OMIC

iSpecimen Launches New Virtual Cancer Sequencing Procurement Program

Aug 30, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Launches New Virtual Cancer Sequencing Procurement Program

iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers

Aug 16, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers

iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers

Aug 9, 2023, 7:30 AM EDT - 2 years ago

iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

Aug 5, 2023, 10:22 AM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

iSpecimen Reports Second Quarter 2023 Financial and Operating Results

Aug 2, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports Second Quarter 2023 Financial and Operating Results

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

Jul 25, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Report Second Quarter 2023 Results on August 2, 2023

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

Jul 6, 2023, 7:30 AM EDT - 2 years ago

Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023

May 23, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

May 6, 2023, 6:25 PM EDT - 2 years ago

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

iSpecimen Reports First Quarter 2023 Results

May 4, 2023, 7:00 AM EDT - 2 years ago

iSpecimen Reports First Quarter 2023 Results

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

Apr 24, 2023, 7:30 AM EDT - 2 years ago

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

StarGazerStox
StarGazerStox Dec. 24 at 10:22 AM
$ISPC The next phase will be defined by how internal discipline offsets macro and competitive headwinds. Long-term optimism depends on disciplined follow-through.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 23 at 6:02 AM
$ISPC RSI: 41.30, MACD: -0.0649 Vol: 0.04, MA20: 0.45, MA50: 0.60 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
peanuta
peanuta Dec. 23 at 1:42 AM
$ISPC swim keeps buying when it gets to 37cent land. why? if this is going to crap out, why?
0 · Reply
peanuta
peanuta Dec. 22 at 8:50 PM
$ISPC i just figured it out. i am the guy buying what you are selling. sux being me.
0 · Reply
peanuta
peanuta Dec. 22 at 8:23 PM
$ISPC always in like a lion, out like a lamb
0 · Reply
FullPorrtDipz
FullPorrtDipz Dec. 22 at 7:33 PM
$ISPC what price the warranta at?
0 · Reply
peanuta
peanuta Dec. 22 at 6:39 PM
$ISPC is today the after hour run? $.50? i hope so. i doubt it. but hope is good.
0 · Reply
peanuta
peanuta Dec. 22 at 5:08 PM
$ISPC for a stock that is screwed, someone keeps buying
0 · Reply
DELETE26
DELETE26 Dec. 22 at 8:21 AM
$ISPC 0.414
0 · Reply
DELETE26
DELETE26 Dec. 19 at 6:19 PM
$ISPC If a stock is falling every day, that stock is screwed.
0 · Reply
isaacwilliams33
isaacwilliams33 Dec. 19 at 5:47 AM
$ISPC accumulation since nov20; double correction pattern; good chance of going a bit lower before finding a bottom. 43cent indicator. $1.95-2.20 resistance. Projected bottom near Feb18th. Keep an eye on this one has good build op of volatility. The picture is of IPSC ahahha common mistake
1 · Reply
StockScanners
StockScanners Dec. 19 at 5:14 AM
$ISPC keep watch if this holds above .70
0 · Reply
peanuta
peanuta Dec. 17 at 11:49 PM
$ISPC is it time for them to raise money again? i am getting impatient
1 · Reply
NormalOne1
NormalOne1 Dec. 16 at 5:03 PM
$ISPC Katherine Field – Track Record as Current Executive 1. Halo Collective Inc. – CEO → Delisted in 2023 2. AERWINS Technologies Inc. – Executive → Delisted in 2024 3. Virpax Pharmaceuticals, Inc. – Director → Delisted in 2025 4. iSpecimen Inc. – CEO → Potential delisting in 2026 (?) 👹👹🔥
0 · Reply
GodzillaX
GodzillaX Dec. 16 at 11:05 AM
$ISPC
0 · Reply
GodzillaX
GodzillaX Dec. 16 at 10:48 AM
$ISPC
0 · Reply
dbr_island
dbr_island Dec. 15 at 11:46 PM
$ISPC watching closely …. 🚨KITT🚨smart money adding here as this is heavily lagging behind its peers RR and SERV Sooner or later this will pay me HUGE I’m telling you I’m even willing to put some of my COIN TSLA profits into KITT👇💰💰💰 $VERO $NCT.X $FEBO $PLAG watching as well
0 · Reply
peanuta
peanuta Dec. 15 at 11:07 PM
$ISPC haha. show us where it says this?
2 · Reply
DDUDDU
DDUDDU Dec. 15 at 10:08 AM
$ISPC Damn, everyone who knew about this in advance already bailed
0 · Reply
GrimReaper1987
GrimReaper1987 Dec. 15 at 10:05 AM
$ISPC Wow… delisted I really thought this stock was going to skyrocket at one point. So was the whole Solana acquisition plan basically a scam?
0 · Reply
peanuta
peanuta Dec. 14 at 9:55 PM
$ISPC set to avg down if needed. have about 10k shares at .45avg. prepared for .30 if need be.
0 · Reply
peanuta
peanuta Dec. 14 at 6:51 PM
$ISPC may 18, 2026. needs to be over $1. https://www.msn.com/en-us/money/savingandinvesting/ispecimen-faces-nasdaq-delisting-notice-for-stock-price/ar-AA1QV2WE
0 · Reply